Promoter holding
64.27%
VB
Voxtur Bio Limited - Due diligence report
A 360° intelligence report on Voxtur Bio Limited: trust score, financial health, credit view, compliance, directors, growth and distress sig…
Full Due-Diligence Report + Documents
- Unlock all financial figures & 5-year trends
- Full trust, health & credit-risk scores
- Director details, charges & MCA documents
₹700
₹449
Save ₹251
excl. GST
Or from ₹279/report with credits
View credit packages
Company Credits – Starter
- One credit unlocks this full due-diligence report
- Use across any company’s report, anytime
- Credits valid for 12 months
Choose your own credit amount
View credit packages
Voxtur Bio Limited — 360° Intelligence Report
Generated from MCA filings & public records77/100
Trust Score
Low Risk
Voxtur Bio Limited is assessed as Low Risk with a Trust Score of 77/100. Voxtur Bio Limited is an active public limited indian non-government company incorporated in 2012, operating in the Healthcare sector. The company has shown revenue growth across its recent filed years. It was profitable in its latest filed year. Based on MCA filings and public records, it currently shows a moderate compliance risk and low financial risk profile.
Report generated on 16 Jul 2026 from the latest processed filings. Voxtur Bio Limited snapshot & full profile →
Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.
02
Score Card
Higher is safer · rule-based & explainableTrust ScoreLow Risk
77/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreModerate
66/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreLow Risk
95/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreLow Risk
80/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreCaution Indicated
45/100
Board strength, DIN status, churn and network.
Growth ScoreLow Risk
95/100
Revenue, profit, asset and hiring momentum.
Distress ScoreLow Risk
80/100
Early-warning signals - higher means fewer warnings.
03
Financial Intelligence Dashboard
Standalone · 5 filed year(s)Unlock the full 5-year financial dashboard with charts and year-wise figures.
Get full accessScores and observations on this page are already computed from the real filings - only the underlying figures are locked.
04
Credit & Compliance Intelligence
Why the scores are what they are
Credit Risk Score: 80/100 Low Risk
- Moderate gearing (D/E 38%).
- Working-capital cover adequate.
- Profitable - internal accruals available.
Charges position: 3 open (14.13 cr) · 2 satisfied (6.35 cr).
Banking relationships (from registered charges)
| Lender | Charges | Amount |
|---|---|---|
| Others | 4 | 48.0 cr |
| Oriental Bank Of Commerce | 1 | 48.0 cr |
Compliance Score: 66/100 Moderate
- Company status is Active as per MCA.
- Balance sheet slightly behind (Mar 2024).
- Litigation present in 2 court forum(s).
- Delayed payments to MSME suppliers disclosed (4 disclosure(s)).
- 1 active GST registration(s).
Legal cases on record (2)
05
Director Intelligence
Stability score: 45/100| Name | DIN / PAN | Designation | Appointed | Tenure | DIN status |
|---|---|---|---|---|---|
| NIKHIL DILIPBHAI BHUTA | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| VEERAAL RAMESH GANDHI | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| RAJASEKHARAN BHASKARAN NAIR | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| Rajasekhar Bhaskeran Nair | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
- 4 directors on the board.
- RAJASEKHARAN BHASKARAN NAIR has DIN status "Deactivated due to non-filing of DIR-3 KYC".
- 3 director exit(s) in the last 3 years.
- Average tenure above 5 years.
Director & KMP remuneration (FY 2024)
| Name | Designation | Total remuneration |
|---|---|---|
| A K Sharma | Managing Director | 2.4 cr |
| R Mehta | Whole-time Director | 1.6 cr |
| S Iyer | CFO | 95.0 L |
Remuneration is disclosed in the latest annual return. Unlock full report
06
Ownership & Group Intelligence
As per FY 2024 annual returnPublic / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
2
Group entities
2
Capital events
10 allotment(s) · 4 transfer(s)
Promoters hold a majority stake - exact percentages are part of the full report.
| Group entity | Relationship | % held |
|---|---|---|
| Microzion Laboratories Private Limited | Subsidiary Company | 74.00% |
| Vitrokits Private Limited | Subsidiary Company | 74.00% |
Key managerial personnel: VEERAAL RAMESH GANDHI (Managing Director) · RAJASEKHARAN BHASKARAN NAIR (CFO)
Full shareholding pattern, group structure & capital events →
07
Risk Intelligence Center
Growth 95 · Distress 80
Growth signals & trust indicators
Revenue acceleration: +1.42 over 4 year(s).
Latest year revenue grew 2.1x.
Profit expanded 24% year-on-year.
Asset base grew 0.86 - capacity expansion.
Net margin improved to 61%.
Operating for 13+ years.
Active EPFO - real payroll on record.
Active GST registration(s).
Distress signals & risk flags
Outside liabilities up 38% in a year.
3 open charge(s) registered - assets are encumbered.
MSME payment delays disclosed - latest outstanding 20.29 Lakh.
2 court case(s) on record - see the legal section for details.
08
Stakeholder Verdicts
Vendor · Banker · InvestorVendor due diligence74/100
Favourable indicators
Suitability as a supplier / customer counterparty.
- Check the compliance flags before onboarding.
- 1 distress signal(s) - see Risk Center.
- Financial filings available for verification.
Banker assessment81/100
Favourable lending indicators
Indicative lending comfort for banks, NBFCs and trade credit.
- Debt capacity assessed from filed statements.
- 3 open charge(s) of 14.13 cr already registered.
- Compliance gaps should be priced into terms.
Investor view90/100
Positive growth indicators
Growth quality and scalability through an investor lens.
- 5 growth signal(s) detected.
- Margin and return trends computable from filings.
- Management churn warrants questions.
09
MCA Filings & Events Timeline
Latest 15 events30 Dec 2024
Last AGM held
Annual general meeting
29 Dec 2024
Director ceased
RAJASEKHARAN BHASKARAN NAIR
03 Dec 2024
Director ceased
VEERAAL RAMESH GANDHI
11 Nov 2024
Director appointed
Rajasekhar Bhaskeran Nair (Cfo)
25 Sep 2024
Director appointed
RAJASEKHARAN BHASKARAN NAIR (CFO)
31 Mar 2024
Latest balance sheet
Filed with ROC
01 Jan 2024
Director ceased
RAMESH JAYANTILAL GANDHI
04 Jan 2023
Director ceased
ZUBER ALIMOHAMMED JAGRALA
30 Dec 2022
Director ceased
NIKHIL DILIPBHAI BHUTA
01 Dec 2022
Director appointed
NIKHIL DILIPBHAI BHUTA (Director)
29 Feb 2020
Charge created
Others - 3.54 cr
04 Nov 2019
Securities allotted
340200 Equity Shares - 11.60 cr raised
06 Jul 2019
Director ceased
WAHEEDA ZUBER JAGRALA
16 Apr 2019
Charge satisfied
Others
Charge satisfied
Oriental Bank Of Commerce
10
Key Observations
Auto-generated from the data aboveRevenue grew 1.42 over the last 4 financial year(s).
Net profit margin moved from 2.1x to 24%.
Debt-to-equity stands at 0.86 - manageable leverage.
Net worth is positive.
4 active director(s) / partner(s); review board churn before relying on management continuity.
1 active GST registration(s) indicate ongoing business operations.
Operates a group structure with 2 subsidiary(ies) - assess on a consolidated basis.
EPFO-registered employer - verifiable payroll history exists.
Promoters hold a majority stake as per the FY 2024 annual return.
Director / KMP remuneration is disclosed in the latest annual return - exact figures available in the full report.
Capital has been raised through 10 security allotment(s) - amounts available in the full report.
| Company | CIN | Location |
|---|---|---|
| Premier Nutraceuticals | U24230MH2003PTC139209 | Mumbai, Maharashtra, India |
| Vedic Cosmeceuticals | U24246DL2003PTC118255 | New Delhi, Delhi, India |
| B.Jain Pharmaceuticals | U24231DL2006PTC146748 | Shahdara, Delhi, India |
| Rotech Healthcare Private Limited | U17309GJ2022PTC129396 | Rajkot, Gujarat, India |
| Diwan Mundhra Bros. Private Limited | U74899DL1991PTC043684 | New Delhi, Delhi, India |
| Smayan Healthcare Private Limited | U24232CH2015PTC035808 | Chandigarh, Chandigarh, India |
| Altra Agro-Chem Private Limited | U24100MH2019PTC327706 | Dombivli East, Maharashtra, India |
| Avantika Medex Private Limited | U51397GJ2007PTC082606 | Ahmedabad, Gujarat, India |
12
Who Uses This Report
CA · CS · Banker · Investor · VendorChartered Accountants (CA)
Verify Voxtur Bio Limited before audits and certifications: compliance score 66/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.
Company Secretaries (CS)
Track statutory health of Voxtur Bio Limited: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.
Bankers & NBFCs
Current banker verdict: Favourable lending indicators. Credit risk score 80/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.
Investors & Analysts
Investor view: Positive growth indicators. Growth score 95/100, margin trends, ownership structure and peer set for Voxtur Bio Limited - screening before a deeper diligence.
Vendors & Procurement Teams
Vendor verdict: Favourable indicators. Trust score 77/100, distress signals and MSME payment-delay disclosures - know whether Voxtur Bio Limited pays its suppliers before you extend credit terms.
Lawyers & Compliance Teams
Litigation footprint (2 case(s) on record), regulatory flags, charge documents trail and director networks for Voxtur Bio Limited - groundwork for KYC, onboarding and disputes.
13
Frequently Asked Questions
Is Voxtur Bio Limited an active company?
Voxtur Bio Limited has MCA status “Active” with a compliance score of 66/100 (Moderate).
Is Voxtur Bio Limited financially healthy?
Voxtur Bio Limited has a Financial Health Score of 95/100 (Low Risk) based on its filed financial statements.
Should I do business with Voxtur Bio Limited?
Its overall Trust Score is 77/100 (Low Risk). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.
Who controls Voxtur Bio Limited?
Promoters hold a majority stake - exact percentages are in the full report. 4 active director(s) are on record.
Does Voxtur Bio Limited have loans or charges against its assets?
3 open charge(s) are registered against its assets, and 2 earlier charge(s) stand satisfied.
Is Voxtur Bio Limited up to date with its ROC filings?
Balance sheet slightly behind (Mar 2024). Overall compliance score: 66/100 (Moderate).
Is it risky to lend to Voxtur Bio Limited?
Its Credit Risk Score is 80/100 (Low Risk). Banker verdict: Favourable lending indicators.
Disclaimer: This report is generated automatically from MCA filings and public records as available
in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the
underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are
not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice.
Verify from official sources and consult a qualified professional before any business, lending or investment decision.
If you represent this company and believe any information is inaccurate or outdated,
report it here and we will review promptly.
